Subantimicrobial-dose doxycycline treatment increases serum cholesterol efflux capacity from macrophages.

Item

http://www.wikidata.org/entity/Q36979142

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Subantimicrobial-dose doxycycl ...... lux capacity from macrophages.

@en

type

Item

label

Subantimicrobial-dose doxycycl ...... lux capacity from macrophages.

@en

prefLabel

Subantimicrobial-dose doxycycl ...... lux capacity from macrophages.

@en

P1476

Subantimicrobial-dose doxycycl ...... lux capacity from macrophages.

@en

P2093

David M Thompson

http://www.w3.org/2001/XMLSchema#string

Hsi-Ming Lee

http://www.w3.org/2001/XMLSchema#string

Julie A Stoner

http://www.w3.org/2001/XMLSchema#string

Lorne M Golub

http://www.w3.org/2001/XMLSchema#string

Timo Sorsa

http://www.w3.org/2001/XMLSchema#string

P2860

Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association

Periodontal disease and biomarkers related to cardiovascular disease

Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review.

The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages.

The effect of subantimicrobial-dose-doxycycline periodontal therapy on serum biomarkers of systemic inflammation: a randomized, double-masked, placebo-controlled clinical trial

Major lipids, apolipoproteins, and risk of vascular disease.

Reverse cholesterol transport and cholesterol efflux in atherosclerosis.

Subantimicrobial dose doxycycline effects on alveolar bone loss in post-menopausal women.

P2888

s00011-013-0626-z

P304

711-720

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00011-013-0626-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236642811

http://www.w3.org/2001/XMLSchema#string

P698

23649042

http://www.w3.org/2001/XMLSchema#string

P932

3700361

http://www.w3.org/2001/XMLSchema#string